Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study by Santoro, Armando, MD, Rimassa, Lorenza, Dr, Borbath, Ivan, MD, Daniele, Bruno, MD, Salvagni, Stefania, MD, Van Laethem, Jean Luc, Prof, Van Vlierberghe, Hans, MD, Trojan, Jörg, Prof, Kolligs, Frank T, Prof, Weiss, Alan, Prof, Miles, Steven, MD, Gasbarrini, Antonio, Prof, Lencioni, Monica, MD, Cicalese, Luca, MD, Sherman, Morris, MD, Gridelli, Cesare, MD, Buggisch, Peter, MD, Gerken, Guido, Prof, Schmid, Roland M, Prof, Boni, Corrado, MD, Personeni, Nicola, MD, Hassoun, Ziad, MD, Abbadessa, Giovanni, MD, Schwartz, Brian, MD, Von Roemeling, Reinhard, MD, Lamar, Maria E, BA, Chen, Yinpu, PhD, Porta, Camillo, MD

Get full text

Pancreatic pleomorphic rhabdomyosarcoma by Shirafkan MD, Ali, Boroumand MD, Nahal, Komak MD, Spogmai, Duchini MD, Andrea, Cicalese MD, Luca

Get full text